Drug
Anticonvulsant drugs used in pregnancy boost risk of birth defects
The United States Food and Drug Administration issued a statement March 4 to warn doctors and patients that Women using topamax or otherwise known as
Opioid painkillers used before or early in pregnancy doubles birth defect risk
By Kathleen Blanchard
Opioid pain medications, taken early in pregnancy and even just before getting pregnant can double the chances of serious birth defects, find U.S. ...
Makers of Avastin get to make their case
by Aimee Keenan-Greene
Genentech, the makers of Avastin, will get a second chance to convince the Food and Drug Administration their drug is a safe and ...
Early intervention for appendicitis in children
By Aimee Keenan-Greene
When it comes to children's appendectomies, early intervention significantly reduces recovery and time spent away from normal activities.
The new non-blinded randomized study in ...
Bone building drugs help fight against cancer
Aimee Keenan-GreeneA new study says the use of oral bisphosphonates - like Fosamax or Boniva - cuts the risk of colorectal cancer by 59 percent ...
60 Lab Studies Now Confirm Cancer Link to a Vaccine You Probably Had as a Child
Posted By Dr. Mercola | February 18 2011
Dr. Maurice Hilleman made astounding revelations in an interview that was cut from The Health Century -- the admission that Merck ...
The Common Drug that Destroys Your Memory
Posted By Dr. Mercola | February 12 2011
In this interview, Dr. Duane Graveline, a family doctor with 23 years experience and a former astronaut, discusses the health implications ...
Chest radiation boosts death risk from heart disease
Feb 4 is the National Wear Red Day, which is an annual event organized by American Heart Association and government agencies to raise awareness about ...
Should Your Kid Be on Statins or GERD Medicine?
By Martha Rosenberg
The patient was overweight and had Type 2 diabetes. He was on Crestor for cholesterol, Atacand for hypertension; the proton pump inhibitor Protonix ...
Avastin and chemo could be a fatal combo
by Aimee Keenan-Greene
Fatal adverse events (FAEs) have been reported in cancer patients treated with the widely used angiogenesis inhibitor bevacizumab (Avastin) in combination with chemotherapy. ...
Home
Set as homepage
Add to favorites
Mobile site
Rss
Plain text
Archive